FDA Approves Twice-Yearly Injectable to Prevent HIV
The FDA has approved a first ever twice-yearly injectable regimen for HIV prevention in adults and adolescents, offering an effective alternative to daily PrEP.
BillionToOne's Jen Hoskovec breaks down the Unity test, the latest in prenatal genetic screening, and what it means for those born with genetic conditions.
Orangetheory Brand President Lauren Cody on the fitness industry's shift from chasing aesthetics to prioritizing longevity and measurable health and wellness.
Peachtree Group CEO Greg Friedman breaks down the Fed's rate decision and the Senate's housing affordability bill and what it means for commercial real estate.